Ariadne Jerue

Ariadne (Goulart) Jerue is an accomplished professional in clinical operations and trial management, currently serving as the Associate Director of Clinical Operations at Oncternal Therapeutics since September 2022. Prior experience includes roles such as Project Director/Global Trial Leader at The Janssen Pharmaceutical Companies of Johnson & Johnson, Associate Director of Clinical Operations at aTyr Pharma, and Senior Clinical Trial Manager roles at Turning Point Therapeutics and eFFECTOR Therapeutics, Inc. Ariadne's career began at Ceregene, Inc. as a Senior Research Associate, progressing through various positions in companies like Pfizer and Halozyme Therapeutics, where expertise in oncology and clinical development was cultivated. Educational qualifications include a Clinical Trial Management Certificate from UC San Diego and a Master of Science in Experimental Human Biology from UERJ.